Cochrane Abstracts
Inhaled hyperosmolar agents for bronchiectasis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Hyperosmolar Agents for Bronchiectasis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439152/0/Inhaled_hyperosmolar_agents_for_bronchiectasis.
Inhaled hyperosmolar agents for bronchiectasis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439152/0/Inhaled_hyperosmolar_agents_for_bronchiectasis. Accessed March 7, 2026.
Inhaled hyperosmolar agents for bronchiectasis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439152/0/Inhaled_hyperosmolar_agents_for_bronchiectasis
Inhaled Hyperosmolar Agents for Bronchiectasis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 March 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439152/0/Inhaled_hyperosmolar_agents_for_bronchiectasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled hyperosmolar agents for bronchiectasis
ID - 439152
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439152/0/Inhaled_hyperosmolar_agents_for_bronchiectasis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
